Global Clinical Nutrition for Diabetes Care Market Report 2024

The clinical nutrition for diabetes care market size has grown strongly in recent years. It will grow from $2.72 billion in 2023 to $2.93 billion in 2024 at a compound annual growth rate (CAGR) of 7.9%. The historical growth can be attributed to several factors, including advocacy by medical professionals, the rise in lifestyle diseases, increased awareness among consumers, development of healthcare infrastructure, and the growing prevalence of diabetes.

The clinical nutrition for diabetes care market size is expected to see strong growth in the next few years. It will grow to $4 billion in 2028 at a compound annual growth rate (CAGR) of 8.1%. The anticipated growth in the forecast period can be attributed to factors such as insurance coverage for diabetes management, healthcare expenditure, the obesity epidemic, the aging population, and the increasing prevalence of diabetes. Major trends expected in the forecast period encompass an increasing focus on immune-supportive nutrition, plant-based nutrition, functional foods and supplements, integration of digital health technologies, and the development of personalized nutrition plans.

The rise in diabetes prevalence is poised to drive the expansion of the clinical nutrition for diabetes care market in the coming years. Diabetes, characterized by elevated blood sugar levels due to insufficient insulin production or ineffective insulin utilization, is influenced by factors such as sedentary lifestyles, poor dietary choices, genetic predisposition, and aging populations. Clinical nutrition for diabetes care plays a pivotal role in aiding patients in managing their condition through tailored dietary plans that regulate blood sugar levels, facilitate weight management, and mitigate complications risk. For instance, as per the International Diabetes Federation, the global number of individuals aged 20-79 with diabetes reached 537 million in 2021, projected to escalate to 643 million by 2030 and 783 million by 2045. Consequently, the uptick in diabetes prevalence is propelling the growth of the clinical nutrition for diabetes care market.

Key players in the clinical nutrition for diabetes care sector are actively developing specialized nutritional formulations to cater to the distinct dietary requirements of diabetic patients, focusing on blood sugar level management and overall health support. These formulations offer balanced nutrition, blood sugar control, and holistic health benefits for diabetes patients. For example, in December 2021, Danone India unveiled Protinex Diabetes Care, a scientifically formulated product addressing the nutritional needs of Indian diabetes patients. Fortified with 26 essential vitamins and minerals, the product, available in vanilla flavor, boasts low fat content, no added sugar, and reduced calories, making it a nutritious option for diabetic individuals. Notably, it stands as the sole product in the powder nutrition category with a low Glycemic Index (GI) of 17, aiding in blood sugar level management.

In June 2023, Abbott Laboratories, a US-based healthcare and medical devices company specializing in specialized nutritional products, forged a partnership with the American Diabetes Association (ADA). This collaboration aims to spearhead innovative solutions for diabetes management and care by developing advanced technologies, educational materials, and support systems to empower individuals living with diabetes. The American Diabetes Association (ADA), a US-based nonprofit organization, is dedicated to raising diabetes awareness and providing resources for diabetes education.

Major companies operating in the clinical nutrition for diabetes care market are Pfizer Inc., Bayer AG, Sanofi-Aventis LLC, Abbott Laboratories, Roche Holdings Inc, Medtronic plc, Danone SA, Eli Lilly and Company, Amgen Inc., Senseonics Holdings Inc., Teva Pharmaceutical Industries Ltd, Baxter International Inc., B. Braun Melsungen AG, Glanbia plc, Perrigo Company plc, Dexcom Inc., Nestlé Health Science S.A., Tandem Diabetes Care, Nutricia International Private Limited, MannKind Corp, Omada Health, Senseonics Holdings Inc., Diasome Pharmaceuticals Inc., Zucara Therapeutics Inc, Victus Inc.

North America was the largest region in the clinical nutrition for diabetes care market in 2023. The regions covered in the clinical nutrition for diabetes care market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the clinical nutrition for diabetes care market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Clinical nutrition for diabetes care involves providing specialized dietary guidance and nutritional support to individuals managing diabetes, encompassing personalized assessments, meal planning, and education on carbohydrate management, glycemic control, and lifestyle modifications. The primary objective is to optimize nutrition, regulate blood sugar levels, prevent complications, and improve overall health outcomes for those with diabetes.

The main products in the clinical nutrition for diabetes care market include oral nutrition, parenteral nutrition, and enteral feeding formulas. Oral nutrition refers to dietary supplements, drinks, or foods consumed orally to meet the nutritional needs of individuals with diabetes, aiming to effectively manage blood sugar levels. These products cater to patients at various stages of adulthood and pediatrics and are distributed through various channels including online, retail, and institutional sales.

The clinical nutrition for diabetes care market research report is one of a series of new reports that provides clinical nutrition for diabetes care market statistics, including clinical nutrition for diabetes care industry global market size, regional shares, competitors with a clinical nutrition for diabetes care market share, detailed clinical nutrition for diabetes care market segments, market trends and opportunities, and any further data you may need to thrive in the clinical nutrition for diabetes care industry. This clinical nutrition for diabetes care market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The clinical nutrition for diabetes care market consists of revenues earned by entities by providing services such as medical nutrition therapy, dietary counseling, and diabetes self-management education and support. The market value includes the value of related goods sold by the service provider or included within the service offering. The clinical nutrition for diabetes care market also includes sales of oral nutrition supplements, enteral nutrition, glucose control formulas, and low-glycemic index foods. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.